180 related articles for article (PubMed ID: 931204)
1. Tamoxifen (antiestrogen) therapy in advanced breast cancer.
Kiang DT; Kennedy BJ
Ann Intern Med; 1977 Dec; 87(6):687-90. PubMed ID: 931204
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogen-induced remissions in stage IV breast cancer.
Manni A; Trujillo J; Marshall JS; Pearson OH
Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.
Pérez Carrión R; Alberola Candel V; Calabresi F; Michel RT; Santos R; Delozier T; Goss P; Mauriac L; Feuilhade F; Freue M
Ann Oncol; 1994; 5 Suppl 7():S19-24. PubMed ID: 7873457
[TBL] [Abstract][Full Text] [Related]
5. [The antiestrogen tamoxifen in advanced breast cancer (author's transl)].
Margreiter R
Langenbecks Arch Chir; 1980; 351(4):249-62. PubMed ID: 6779066
[TBL] [Abstract][Full Text] [Related]
6. Fulvestrant: a review of its use in hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
McKeage K; Curran MP; Plosker GL
Drugs; 2004; 64(6):633-48. PubMed ID: 15018596
[TBL] [Abstract][Full Text] [Related]
7. Treatment of breast cancer with antiestrogen: approach to medical hypophysectomy?
Manni A; Trujillo J; Brodkey J; Marshall JS; Pearson OH
Trans Assoc Am Physicians; 1977; 90():342-52. PubMed ID: 611666
[TBL] [Abstract][Full Text] [Related]
8. Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.
Sawka CA; Pritchard KI; Paterson AH; Sutherland DJ; Thomson DB; Shelley WE; Myers RE; Mobbs BG; Malkin A; Meakin JW
Cancer Res; 1986 Jun; 46(6):3152-6. PubMed ID: 3084082
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen efficacy in advanced breast cancer previously treated with endocrine and cytotoxic therapy.
De Lena M; Brambilla C; Jirillo A
Tumori; 1980 Jun; 66(3):339-48. PubMed ID: 7445113
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer.
Beex L; Pieters G; Smals A; Koenders A; Benraad T; Kloppenborg P
Cancer Treat Rep; 1981; 65(3-4):179-85. PubMed ID: 7237448
[TBL] [Abstract][Full Text] [Related]
11. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
Novoa Vargas A; Font López KC; Amador DD
Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the estrogenic effects of tamoxifen and 17 beta-estradiol in postmenopausal women.
Helgason S; Wilking N; Carlström K; Damber MG; von Schoultz B
J Clin Endocrinol Metab; 1982 Feb; 54(2):404-8. PubMed ID: 6798066
[TBL] [Abstract][Full Text] [Related]
13. Effect of tamoxifen treatment on estrogen metabolism in postmenopausal women with advanced breast cancer.
Levin J; Markham MJ; Greenwald ES; O'Connor JF; Zumoff B; Fukushima DK
Anticancer Res; 1982; 2(6):377-80. PubMed ID: 7168557
[TBL] [Abstract][Full Text] [Related]
14. Antiestrogen treatment of breast cancer: an overview.
Pearson OH; Manni A; Arafah BM
Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogens in treatment of breast cancer.
Tagnon HJ
Cancer; 1977 Jun; 39(6 Suppl):2959-64. PubMed ID: 326387
[TBL] [Abstract][Full Text] [Related]
16. Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer.
Namer M; Lalanne C; Baulieu EE
Cancer Res; 1980 May; 40(5):1750-2. PubMed ID: 7371003
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of hormone-sensitive breast cancer progression on antiestrogen therapy. Implications for treatment and protocol planning.
Pommier RF; Woltering EA; Keenan EJ; Fletcher WS
Arch Surg; 1987 Nov; 122(11):1311-6. PubMed ID: 2960297
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum estrogen levels in women during tamoxifen therapy.
Lum SS; Woltering EA; Fletcher WS; Pommier RF
Am J Surg; 1997 May; 173(5):399-402. PubMed ID: 9168075
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial.
Gockerman JP; Spremulli EN; Raney M; Logan T
Cancer Treat Rep; 1986 Oct; 70(10):1199-203. PubMed ID: 3530447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]